GlassScriptPhysician profile
Blake C Landry
NPI 1417953597
$1,336.15
in general payments reported to CMS, 2019-2025
15 companies · $177 in 2025
The $177 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.33 · 2020: $72.70 · 2021: $187 · 2022: $295 · 2023: $325 · 2024: $226 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $728.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $727.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $425.64 | 2021-2025 | |
| Abbvie INC. | $397.88 | 2021-2023 | |
| Avion Pharmaceuticals | $130.23 | 2021-2023 | Balcoltra |
| Hologic Sales and Service, LLC | $107.31 | 2020-2025 | Aptima |
| Astellas Pharma US INC | $105.84 | 2023-2025 | Veozah |
| Electromed, INC. | $41.00 | 2019 | |
| Therapeuticsmd, INC. | $38.93 | 2019-2021 | |
| Pfizer INC. | $21.38 | 2020-2022 | |
| Heron Therapeutics, INC. | $21.35 | 2023 | Zynrelef |
| Circassia INC. | $19.46 | 2020 | |
| Meditrina | $15.94 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $11.19 | 2020 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blake Landry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.